scholarly journals Chiari Network and Patent Foramen Ovale Associated with Stroke

2021 ◽  
Author(s):  
Adwaiy Manerikar ◽  
S. Chris Malaisrie
2008 ◽  
Vol 336 (6) ◽  
pp. 458-461 ◽  
Author(s):  
Gianluca Rigatelli ◽  
Fabio Dell’Avvocata ◽  
Paolo Cardaioli ◽  
Massimo Giordan ◽  
Gabriele Braggion ◽  
...  

2020 ◽  
Vol 2 (7) ◽  
pp. 1025-1028
Author(s):  
Rimmy Garg ◽  
Tyler Wark ◽  
John Dudley ◽  
James Robertson

2021 ◽  
Vol 77 (18) ◽  
pp. 2601
Author(s):  
Amandeep Goyal ◽  
Tarun Dalia ◽  
Jonathan Chandler ◽  
Sagar Ranka ◽  
Prince Sethi ◽  
...  

2020 ◽  
Vol 75 (11) ◽  
pp. 2856
Author(s):  
Rimmy Garg ◽  
Tyler Wark ◽  
John B. Dudley ◽  
James Robertson

2009 ◽  
Vol 4 (1) ◽  
pp. 76
Author(s):  
James Slater ◽  
Mark Fisch ◽  
◽  

William Harvey was the first scientist to describe the heart as consisting of separate right- and left-sided circulations. Our understanding of the heart’s anatomy and physiology has grown significantly since this landmark discovery in 1628. Today, we recognise not only the importance of these separate systems, but also the specific tissue that divides them. Our growing understanding of the inter-atrial septum has allowed us to identify defects within this structure and develop effective percutaneous devices for closure of these defects in the adult patient. This article discusses the formation of a patent foramen ovale (PFO) and atrial septal defect (ASD). In addition, we describe the medical illnesses caused by these defects and summarise the indications and risks related to percutaneous closure of these defects. We also report the most up-to-date transcatheter therapeutic options for closure of these common congenital defects in the adult patient.


2011 ◽  
Vol 6 (1) ◽  
pp. 67
Author(s):  
Antonio L Bartorelli ◽  
Claudio Tondo ◽  
◽  

Innovative percutaneous procedures for stroke prevention have emerged in the last two decades. Transcatheter closure of the patent foramen ovale (PFO) is performed in patients who suffered a cryptogenic stroke or a transient ischaemic attach (TIA) in order to prevent recurrence of thromboembolic events. Percutaneous occlusion of the left atrial appendage (LAA) has been introduced to reduce stroke risk in patients with atrial fibrillation (AF). The role of PFO and LAA in the occurrence of cerebrovascular events and the interventional device-based therapies to occlude the PFO and LAA are discussed.


Sign in / Sign up

Export Citation Format

Share Document